Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 12570712)

Published in Curr Med Chem on February 01, 2003

Authors

M A Fuertes1, J Castilla, C Alonso, J M Pérez

Author Affiliations

1: Departamento de Química Inorgánica, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049-Madrid, Spain.

Articles citing this

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94

Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci U S A (2009) 2.21

Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci U S A (2010) 1.95

Activation of the DNA damage checkpoint in yeast lacking the histone chaperone anti-silencing function 1. Mol Cell Biol (2004) 1.94

Cytoplasmic initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol (2008) 1.75

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front Oncol (2013) 1.42

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) (2012) 1.38

RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res (2004) 1.33

Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol (2007) 1.21

Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol (2009) 1.14

Pneumatosis intestinalis and portal venous gas without bowel ischemia in a patient treated with irinotecan and cisplatin. Dig Dis Sci (2007) 1.13

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol (2009) 1.13

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J Bioenerg Biomembr (2007) 1.12

Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflamm (Lond) (2010) 1.07

WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol (2004) 1.02

Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment. Int J Hyperthermia (2013) 1.00

Npr2, yeast homolog of the human tumor suppressor NPRL2, is a target of Grr1 required for adaptation to growth on diverse nitrogen sources. Eukaryot Cell (2010) 0.96

RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae. ACS Chem Biol (2011) 0.95

Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. Biophys J (2007) 0.92

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer. Bioanalysis (2013) 0.88

Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance. PLoS One (2011) 0.87

Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts. Gynecol Oncol (2008) 0.86

Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles. J Biol Inorg Chem (2005) 0.86

Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells. J Biol Inorg Chem (2013) 0.86

Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375. Theranostics (2016) 0.85

Enzymatic processing of platinated RNAs. J Am Chem Soc (2010) 0.85

Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer. Am J Nucl Med Mol Imaging (2012) 0.84

Effects of oxaliplatin on mouse myenteric neurons and colonic motility. Front Neurosci (2013) 0.84

Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism. Met Based Drugs (2008) 0.83

Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53. PLoS One (2014) 0.82

Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells. PLoS One (2014) 0.82

Repopulation of ovarian cancer cells after chemotherapy. Cancer Growth Metastasis (2013) 0.82

Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. Br J Pharmacol (2014) 0.81

Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations. Chemother Res Pract (2011) 0.81

Ethanol and vitamin D receptor in T cell apoptosis. J Neuroimmune Pharmacol (2012) 0.80

Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model. Mol Cancer Ther (2015) 0.80

The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget (2016) 0.79

Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells. Onco Targets Ther (2015) 0.79

The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev (2013) 0.79

Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells. Oncol Lett (2014) 0.79

Deficit of p66ShcA restores redox-sensitive stress response program in cisplatin-induced acute kidney injury. Exp Mol Pathol (2013) 0.78

Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival. Oncotarget (2016) 0.78

Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents. Met Based Drugs (2007) 0.78

Heterogeneity of excision repair cross-complementation group 1 gene expression in non-small-cell lung cancer patients. Mol Clin Oncol (2014) 0.78

Implications of therapy-induced selective autophagy on tumor metabolism and survival. Int J Cell Biol (2012) 0.78

Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells. Acta Pharmacol Sin (2011) 0.78

Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets. Met Based Drugs (2011) 0.77

Effects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomics. Acta Pharm Sin B (2015) 0.77

Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. Biochem Pharmacol (2014) 0.76

Effects of cisplatin on the contractile function of thoracic aorta of Sprague-Dawley rats. Biomed Rep (2014) 0.75

Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF. Biol Open (2016) 0.75

DNA electrochemical biosensor for metallic drugs at physiological conditions. J Electroanal Chem (Lausanne) (2014) 0.75

Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med (2016) 0.75

Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation. Oncotarget (2016) 0.75

Cisplatin cytotoxicity is dependent on mitochondrial respiration in Saccharomyces cerevisiae. Iran J Basic Med Sci (2017) 0.75

Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents. J Nanotechnol Eng Med (2014) 0.75

Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin. Microbiology (2014) 0.75

Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci (2017) 0.75

The influence of oxo-bridged binuclear gold(III) complexes on Na/K-ATPase activity: a joint experimental and theoretical approach. J Biol Inorg Chem (2017) 0.75

Articles by these authors

Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol (2001) 2.56

A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78

Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69

Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68

Awareness and use of nonoccupational HIV post-exposure prophylaxis among people receiving rapid HIV testing in Spain. HIV Med (2012) 1.50

A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res (1988) 1.47

Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. J Med Chem (1998) 1.47

Vagal system involvement in changes in small bowel motility during restraint stress: an experimental study in the dog. Br J Surg (1993) 1.46

Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med (1990) 1.43

Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med (1990) 1.42

[Trend of HIV seroprevalence among mothers of new-born infants from 1996 to 1999]. Med Clin (Barc) (2000) 1.40

[Incidence and risk factors of the association of AIDS and tuberculosis in Spain]. Med Clin (Barc) (1998) 1.40

[Interrelationship between the duration of HIV infection, viral load and CD4 positive lymphocyte count]. Med Clin (Barc) (1998) 1.38

[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]. Med Clin (Barc) (1996) 1.38

Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol (2003) 1.38

Characterization of a non-long terminal repeat retrotransposon cDNA (L1Tc) from Trypanosoma cruzi: homology of the first ORF with the ape family of DNA repair enzymes. J Mol Biol (1995) 1.36

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat (2001) 1.36

De novo induction of amyloid-β deposition in vivo. Mol Psychiatry (2011) 1.32

3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res (1998) 1.31

Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol (2000) 1.29

Sociodemographic characteristics and HIV risk behaviour patterns of male sex workers in Madrid, Spain. AIDS Care (2001) 1.29

Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment. Breast Cancer Res Treat (2009) 1.25

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today (2000) 1.21

Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect (2003) 1.20

Analysis of post-transcriptional regulation operating on transcription products of the tandemly linked Leishmania infantum hsp70 genes. J Biol Chem (1997) 1.19

Do non-long terminal repeat retrotransposons have nuclease activity? Trends Biochem Sci (1996) 1.17

The role of charged amphipathic helices in the structure and function of surfactant protein B. J Pept Res (2005) 1.16

[Herpes zoster incidence in diabetic patients]. An Sist Sanit Navar (2013) 1.16

Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med (2002) 1.15

Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res (2012) 1.14

[Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991)]. Bull Soc Pathol Exot (1995) 1.14

Sarcoptes mite from collection to DNA extraction: the lost realm of the neglected parasite. Parasitol Res (2009) 1.13

Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol (1998) 1.13

The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology (1998) 1.11

African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology (1996) 1.10

Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. Am J Gastroenterol (1997) 1.10

Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization. J Virol (1996) 1.10

Pd(II) and Pt(II) complexes with aromatic diamines: study of their interaction with DNA. J Inorg Biochem (2004) 1.09

Is ITS-2 rDNA suitable marker for genetic characterization of Sarcoptes mites from different wild animals in different geographic areas? Vet Parasitol (2008) 1.09

Genomic organization and expression of two independent gene arrays coding for two antigenic acidic ribosomal proteins of Leishmania. J Biol Chem (1993) 1.08

In situ hybridization of nuclear and cytoplasmic RNA to locus 2-48BC in Drosophila hydei. Chromosoma (1978) 1.08

Time trend in incidence of HIV seroconversion among homosexual men repeatedly tested in Madrid, 1988--2000. AIDS (2001) 1.08

Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol (1999) 1.07

Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun (1998) 1.06

Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J Clin Microbiol (2006) 1.06

Characterization and molecular basis of heterogeneity of the African swine fever virus envelope protein p54. J Virol (1994) 1.06

Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. Biochim Biophys Acta (1999) 1.06

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect (2009) 1.05

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group. Clin Infect Dis (1996) 1.04

Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill (2012) 1.04

Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03

Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines. J Inorg Biochem (1998) 1.03

Z-DNA in transcriptionally active chromosomes. Proc Natl Acad Sci U S A (1987) 1.03

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun (2001) 1.02

Identification of a putative regulatory element in the 3'-untranslated region that controls expression of HSP70 in Leishmania infantum. Mol Biochem Parasitol (2000) 1.02

A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat (2006) 1.02

The open reading frame 1 of the L1Tc retrotransposon of Trypanosoma cruzi codes for a protein with apurinic-apyrimidinic nuclease activity. J Biol Chem (1997) 1.01

Characterization of Le(x), Le(y) and A Le(y) antigen determinants in KDN-containing O-linked glycan chains from Pleurodeles waltlii jelly coat eggs. FEBS Lett (1992) 1.00

Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol (2006) 1.00

Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00

HotSHOT Plus ThermalSHOCK, a new and efficient technique for preparation of PCR-quality mite genomic DNA. Parasitol Res (2008) 0.99

Locations of Z-DNA in polytene chromosomes. J Cell Biol (1985) 0.98

Traumatic disruption of the pancreatic duct: diagnosis with MR pancreatography. AJR Am J Roentgenol (2001) 0.98

Computer aided diagnosis system for Alzheimer disease using brain diffusion tensor imaging features selected by Pearson's correlation. Neurosci Lett (2011) 0.98

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill (2015) 0.98

The location of 5S (ribosomal) RNA genes in Drosophila hydei. Chromosoma (1975) 0.98

Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol (1999) 0.97

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet Immunol Immunopathol (2003) 0.97

Mating system, sex ratio, and persistence of females in the gynodioecious shrub Daphne laureola L. (Thymelaeaceae). Heredity (Edinb) (2005) 0.96

Skin-scale genetic structure of Sarcoptes scabiei populations from individual hosts: empirical evidence from Iberian ibex-derived mites. Parasitol Res (2008) 0.96

Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A. Eur J Biochem (1992) 0.96

Molecular characterization of KMP11 from Trypanosoma cruzi: a cytoskeleton-associated protein regulated at the translational level. DNA Cell Biol (2000) 0.96

During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein. Parasitology (1996) 0.96

Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol (2000) 0.96

Oligomannosides or oligosaccharide-lipids as potential substrates for rat liver cytosolic alpha-D-mannosidase. Biochem J (1996) 0.96

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens (2007) 0.95

Characterization of a highly repeated interspersed DNA sequence of Trypanosoma cruzi: its potential use in diagnosis and strain classification. Mol Biochem Parasitol (1992) 0.95

Persistence of antibodies to Trypanosoma brucei gambiense after treatment of human trypanosomiasis in Uganda. Lancet (1992) 0.95

In situ immunofluorescent visualization of chromosomal transcripts in polytene chromosomes. Chromosoma (1982) 0.94

Ossification of the appendicular skeleton in the Spanish Ibex Capra pyrenaica Schinz, 1838 (Artiodactyla: Bovidae), with regard to determination of age. Anat Histol Embryol (2004) 0.94

Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients. Scand J Immunol (2005) 0.94

Genomic repetitive DNA elements of Trypanosoma cruzi. Parasitol Today (1996) 0.94

Synthesis and characterization of novel palladium(II) complexes of bis(thiosemicarbazone). Structure, cytotoxic activity and DNA binding of Pd(II)-benzyl bis(thiosemicarbazonate). J Inorg Biochem (1999) 0.94

Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol (1992) 0.94

Diagnostic markers of viral hepatitis B and C. Gut (1993) 0.94

A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels. Br J Cancer (2011) 0.94

Specific serodiagnosis of human leishmaniasis with recombinant Leishmania P2 acidic ribosomal proteins. Clin Diagn Lab Immunol (1996) 0.93

Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill (2012) 0.93

Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors. Eur J Immunol (1990) 0.93

Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virol (1998) 0.93

Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill (2013) 0.92

Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen (2007) 0.92

Serodiagnosis of African swine fever using the recombinant protein p30 expressed in insect larvae. J Virol Methods (2000) 0.92

Molecular cloning and analysis of expression of the Leishmania infantum histone H4 genes. Mol Biochem Parasitol (1997) 0.92

Use of computed tomography as a non-invasive method for diagnosing cephenemyiosis in roe deer (Capreolus capreolus). Med Vet Entomol (2014) 0.92

During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response. Acta Trop (1996) 0.92

[Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006]. An Sist Sanit Navar (2008) 0.92

Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis (2000) 0.92